Based upon the results of this study (Figure 4a), VEGFR-1 mRNA expression in peripheral blood may be useful for choice of adjuvant chemotherapy in Luminal type (HER2 negative) breast cancer. The gene discussed is FLT1; the disease is breast carcinoma.